Rosetta Genomics, Ltd. (ROSG) Starts Presentation at LD Micro Conference

Rosetta Genomics, Ltd. is involved in developing and providing microRNA-based molecular diagnostics. Since 2000, Rosetta’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically-validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, the company is working on the application of these technologies in the development and commercialization of a full range of microRNA-based diagnostic tools and therapeutics. Rosetta’s cancer testing services are commercially available through its Philadelphia-based lab. For more information, visit the company’s website at www.rosettagenomics.com.